CN104168829B - 糖尿病治疗支援装置、HbA1c推断值计算方法 - Google Patents

糖尿病治疗支援装置、HbA1c推断值计算方法 Download PDF

Info

Publication number
CN104168829B
CN104168829B CN201280071342.1A CN201280071342A CN104168829B CN 104168829 B CN104168829 B CN 104168829B CN 201280071342 A CN201280071342 A CN 201280071342A CN 104168829 B CN104168829 B CN 104168829B
Authority
CN
China
Prior art keywords
blood glucose
value
meal
data
hba1c
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280071342.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN104168829A (zh
Inventor
时田宗雄
中嶋聪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omron Healthcare Co Ltd
Original Assignee
Omron Healthcare Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omron Healthcare Co Ltd filed Critical Omron Healthcare Co Ltd
Publication of CN104168829A publication Critical patent/CN104168829A/zh
Application granted granted Critical
Publication of CN104168829B publication Critical patent/CN104168829B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7278—Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/486—Biofeedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Signal Processing (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Primary Health Care (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Epidemiology (AREA)
CN201280071342.1A 2012-03-12 2012-11-12 糖尿病治疗支援装置、HbA1c推断值计算方法 Active CN104168829B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-054382 2012-03-12
JP2012054382A JP5900044B2 (ja) 2012-03-12 2012-03-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム
PCT/JP2012/079284 WO2013136585A1 (ja) 2012-03-12 2012-11-12 糖尿病治療支援装置、糖尿病治療支援方法、糖尿病治療支援プログラム

Publications (2)

Publication Number Publication Date
CN104168829A CN104168829A (zh) 2014-11-26
CN104168829B true CN104168829B (zh) 2016-12-07

Family

ID=49160538

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280071342.1A Active CN104168829B (zh) 2012-03-12 2012-11-12 糖尿病治疗支援装置、HbA1c推断值计算方法

Country Status (5)

Country Link
US (1) US9131903B2 (enExample)
JP (1) JP5900044B2 (enExample)
CN (1) CN104168829B (enExample)
DE (1) DE112012006019T5 (enExample)
WO (1) WO2013136585A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102393711B1 (ko) 2013-10-17 2022-05-04 더 제너럴 하스피탈 코포레이션 자가면역 질환의 치료에 반응하는 대상체의 식별 방법 및 그의 치료를 위한 조성물
WO2016103390A1 (ja) * 2014-12-25 2016-06-30 株式会社日立製作所 インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法
KR101807854B1 (ko) * 2016-01-29 2017-12-12 주식회사 아이센스 임신성 당뇨병 환자를 위한 식사 시간 정보의 제공 방법
US11039986B2 (en) 2016-02-25 2021-06-22 Samsung Electronics Co., Ltd. Chronotherapeutic dosing of medication and medication regimen adherence
WO2017187212A1 (en) * 2016-04-28 2017-11-02 77 Elektronika Müszeripari Kft. Data processing method for blood glucose measuring, blood glucose meter, blood glucose measurement system, and computer program and data carrier therefor
KR20190006955A (ko) * 2016-05-13 2019-01-21 에이껜 가가꾸 가부시끼가이샤 측정 대상 물질의 비교 대상 물질에 대한 비율을 구하는 방법, 프로그램, 기억 매체 및 장치
US11464447B2 (en) 2016-06-30 2022-10-11 Novo Nordisk A/S Regimen adherence measure for insulin treatment based on glucose measurements and insulin pen data
CN108283486B (zh) * 2017-01-09 2021-04-09 腾讯科技（深圳）有限公司 测量数据的处理方法及装置
JP7149053B2 (ja) * 2017-04-25 2022-10-06 株式会社田中金属製作所 糖尿病予防又は改善用液状物
EP3917378B8 (en) * 2019-01-28 2025-04-23 MediBeacon Inc. Systems and methods for home transdermal gfr monitoring
CA3157672A1 (en) * 2019-11-25 2021-06-03 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
CN113128301A (zh) * 2019-12-31 2021-07-16 苏州三六零智能安全科技有限公司 视频鉴黄方法、系统、存储介质及其计算机设备
WO2025064603A1 (en) * 2023-09-21 2025-03-27 Abbott Diabetes Care Inc. Methods, devices, and systems for adjusting laboratory hba1c values

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007005170A2 (en) * 2005-06-29 2007-01-11 Medtronic Minimed, Inc. Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
JP2008213098A (ja) * 2007-03-06 2008-09-18 Mitsubishi Heavy Ind Ltd 割り出しテーブル
CN101288593A (zh) * 2007-03-20 2008-10-22 生命扫描有限公司 用于糖尿病管理的通讯媒介
JP4273036B2 (ja) * 2004-05-12 2009-06-03 中 奥村 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
CN101750499A (zh) * 2008-08-15 2010-06-23 生命扫描苏格兰有限公司 分析物测量方法和系统
WO2010149392A1 (en) * 2009-06-26 2010-12-29 Roche Diagnostics Gmbh Method, system, and computer program product for providing both an estimated true mean blood glucose value and estimated glycated hemoglobin (hba1c) value from structured spot measurements of blood glucose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001245900A (ja) 2000-03-02 2001-09-11 Arkray Inc グラフおよびグラフの表示方法並びにグラフ表示装置
JPWO2006009199A1 (ja) 2004-07-21 2008-05-01 松下電器産業株式会社 血糖値管理システム
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
JP4889116B2 (ja) 2007-03-20 2012-03-07 旭化成ファーマ株式会社 肝疾患における正確な血糖コントロール状態および肝機能を算出する方法
JP5429586B2 (ja) * 2007-03-30 2014-02-26 株式会社タニタ 血糖状態推定方法及び装置
JP2012024439A (ja) * 2010-07-27 2012-02-09 Seiko Epson Corp 血糖値予測システム

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4273036B2 (ja) * 2004-05-12 2009-06-03 中 奥村 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
WO2007005170A2 (en) * 2005-06-29 2007-01-11 Medtronic Minimed, Inc. Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
JP2008213098A (ja) * 2007-03-06 2008-09-18 Mitsubishi Heavy Ind Ltd 割り出しテーブル
CN101288593A (zh) * 2007-03-20 2008-10-22 生命扫描有限公司 用于糖尿病管理的通讯媒介
CN101750499A (zh) * 2008-08-15 2010-06-23 生命扫描苏格兰有限公司 分析物测量方法和系统
WO2010149392A1 (en) * 2009-06-26 2010-12-29 Roche Diagnostics Gmbh Method, system, and computer program product for providing both an estimated true mean blood glucose value and estimated glycated hemoglobin (hba1c) value from structured spot measurements of blood glucose

Also Published As

Publication number Publication date
US9131903B2 (en) 2015-09-15
JP2013188240A (ja) 2013-09-26
CN104168829A (zh) 2014-11-26
DE112012006019T5 (de) 2014-12-18
US20150038816A1 (en) 2015-02-05
JP5900044B2 (ja) 2016-04-06
WO2013136585A9 (ja) 2014-07-31
WO2013136585A1 (ja) 2013-09-19

Similar Documents

Publication Publication Date Title
CN104168829B (zh) 糖尿病治疗支援装置、HbA1c推断值计算方法
JP5670576B2 (ja) 携帯型医療機器用の電力管理
JP5323774B2 (ja) 分析物検出のための糖尿病管理装置と選択的にデータを転送する方法
JP5528701B2 (ja) 多レベルユーザーインターフェイスを有する計測器
CN103250157B (zh) 在手持糖尿病管理设备上的结构化血糖试验的可更新性
US20170156642A1 (en) Information Processing Apparatus and User Terminal
JP5802656B2 (ja) 血糖値計測装置、血糖値計測結果の表示方法、および血糖値計測結果の表示制御プログラム
JP5435945B2 (ja) 食後検査時間アラームを有する計測器
CN105452866B (zh) 分析血糖数据并量化胰岛素疗法成功对于失败的系统和方法
CN103168304B (zh) 用于设备的糖尿病管理系统的元数据标签系统
US10060802B1 (en) Intelligent digital thermometer
JP2011523478A (ja) 検体測定及び管理デバイス、並びに関連方法
Palatini et al. Techniques for self‐measurement of blood pressure: limitations and needs for future research
JP6509232B2 (ja) データ管理ユニットおよびその動作方法
JP2003204941A (ja) 生体情報測定器および生体情報測定システム
ES2753356T3 (es) Un procedimiento y un dispositivo para determinar un nivel de glucosa en líquido corporal de un paciente, y un producto de programa informático
JP6117552B2 (ja) 生活習慣病判定支援装置および生活習慣病判定支援システム
US8630808B2 (en) Estimation of diagnostic markers
JP2018175488A (ja) 健康支援装置、健康支援システム、健康支援方法及び健康支援装置のプログラム
WO2022114010A1 (ja) 情報処理装置、情報処理方法及び情報処理プログラム
CN111433859A (zh) 信息处理装置、方法以及程序
CN108882862B (zh) 诊断辅助装置、生物体信息测定装置、诊断辅助方法、以及诊断辅助程序
JP6117499B2 (ja) 唾液検査を用いた生活習慣病判定支援方法
HK1188311B (en) Updatability of structured blood glucose tests on handheld diabetes management devices
HK1188311A (en) Updatability of structured blood glucose tests on handheld diabetes management devices

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant